@article{9b476e84b9464fe483408edf80358d87,
title = "Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma",
author = "Katrien Eger and Lodewijk Pet and Weersink, \{Els J. M.\} and Bel, \{Elisabeth H.\}",
note = "Funding Information: Conflicts of interest: E. J. M. Weersink reports support from Astra Zeneca , GlaxoSmithKline (GSK), Novartis , and Sanofi / Regeneron , outside the submitted work. E. H. Bel reports grants from GSK , Novartis , and Teva , and personal fees from AstraZeneca, GSK, Novartis, Sanofi/Regeneron, Sterna, and Chiesi, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Conflicts of interest: E. J. M. Weersink reports support from Astra Zeneca, GlaxoSmithKline (GSK), Novartis, and Sanofi/Regeneron, outside the submitted work. E. H. Bel reports grants from GSK, Novartis, and Teva, and personal fees from AstraZeneca, GSK, Novartis, Sanofi/Regeneron, Sterna, and Chiesi, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.",
year = "2021",
month = jul,
doi = "10.1016/j.jaip.2021.02.042",
language = "English",
volume = "9",
pages = "2913--2915",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "American Academy of Allergy, Asthma and Immunology",
number = "7",
}
SDG 3 Good Health and Well-being